LifeVantage Q4 Revenue Plunges 23% as Active Accounts Shrink 21%
LFVN sits 65% above its 52-week low of $3.9 on light trading volume (0.3× avg).
Summary
LifeVantage reported Q4 FY2026 revenue of $42.4M, down 23.1% year-over-year, with diluted EPS of $0.10 versus $0.15 a year ago. Full-year revenue fell 20.1% to $182.6M, and active accounts dropped 21.2% to 104,000. The company cited lower orders from its active account base and a decline in MindBody GLP-1 System sales, partially offset by the LoveBiome acquisition. Due to the transition in the CEO role, LifeVantage is not issuing formal guidance for fiscal 2027 at this time. The balance sheet remains debt-free with $14.9M in cash, but the shrinking customer base and revenue decline are material negatives for a company with an $81M market cap.
At the time of this announcement, LFVN was trading at $6.45 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $81.4M. The 52-week trading range was $3.90 to $14.28. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.